Research News From October 1, 2014
advertisement
- Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
- Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals.
- Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.
- A Novel, Stable, Aqueous Glucagon Formulation Using Ferulic Acid as an Excipient.
- Obesity, islet cell autoimmunity and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes.
